Loading...

Cellect Biotechnology Ltd.

APOP•NASDAQ
Healthcare
Biotechnology
$13.17
$0.05(0.38%)

Cellect Biotechnology Ltd. (APOP) Stock Overview

Explore Cellect Biotechnology Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 63.6/100

Key Financials

Market Cap129M
P/E Ratio41.65
EPS (TTM)$-0.85
ROE2.27%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$8.64

APOP Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cellect Biotechnology Ltd. (APOP) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $8.64.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 41.65 and a market capitalization of 129M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Stats data is not available for APOPStats details for APOP are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for APOPAnalyst Recommendations details for APOP are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

CEO

Shai Yarkoni

Employees

12

Headquarters

23 Hata'as Street, Kfar Saba

Founded

2016

Frequently Asked Questions

;